Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
Alimentary Pharmacology & Therapeutics2017Vol. 46(10), pp. 1001–1010
Citations Over TimeTop 10% of 2017 papers
J. Wong, Henry Lik‐Yuen Chan, Y K Tse, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Grace Lai–Hung Wong
Abstract
Patients with chronic viral hepatitis who used statins have a reduced risk of liver decompensation and death compared to non-users in this propensity score weighted landmark analysis.
Related Papers
- → Marginal Structural Models and Causal Inference in Epidemiology(2000)5,443 cited
- → Structural accelerated failure time models for survival analysis in studies with time-varying treatments(2005)163 cited
- → Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis(2021)12 cited
- → Lipid levels in patients with decompensation and mortality after an index hospitalization for acute heart failure(2021)
- → Clinical and prognostic characterization of the patterns of decompensation of liver cirrhosis(2022)